| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
GMED (GMED) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. GMED is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 516.3K | $40.88M | - | |
| Other | 60.4K | $4.78M | - | |
| CEO | 40.0K | $3.17M | - | |
| Dir | 25.0K | $1.98M | - | |
| Dir | 15.4K | $1.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2022 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sale+OE | 2,500 | $75.59 | $188,962.50 | -100% | -24.0% | -24.7% | |
| Mar 15, 2022 | Tobin James R60 | Director | Sale+OE | 8,850 | $65.47 | $579,418.35 | -100% | -13.0% | -20.3% | |
| Mar 10, 2022 | Tobin James R60 | Director | Sale+OE | 14,484 | $70.65 | $1,023,246.00 | -100% | -12.7% | -22.7% | |
| Aug 19, 2021 | Pfeil Keith W69 | SVP, Chief Financial Officer | Sale+OE | 833 | $76.13 | $63,416.29 | -100% | -8.7% | -16.1% | |
| Aug 2, 2021 | Pfeil Keith W69 | SVP, Chief Financial Officer | Sale+OE | 833 | $83.24 | $69,338.92 | -100% | -5.7% | -27.4% | |
| Jul 19, 2021 | Pfeil Keith W69 | SVP, Chief Financial Officer | Sale+OE | 834 | $78.25 | $65,260.50 | -100% | -2.3% | -25.8% | |
| Jul 2, 2021 | Scavilla Daniel T55 | EVP, Chief Commercial Officer | Sale+OE | 100,000 | $78.41 | $7,841,224.00 | -99.6% | -2.7% | -26.7% | |
| Jul 1, 2021 | Pfeil Keith W69 | SVP, Chief Financial Officer | Sale+OE | 833 | $77.43 | $64,499.19 | -100% | +0.4% | -26.6% | |
| Jun 25, 2021 | Pfeil Keith W69 | SVP, Chief Financial Officer | Sale+OE | 27,479 | $75.04 | $2,062,024.16 | -100% | +4.5% | -25.3% | |
| May 10, 2021 | Tobin James R60 | Director | Sale+OE | 25,000 | $71.96 | $1,799,000.00 | -100% | +12.8% | -13.8% |